FTC, DOJ to Heighten Reporting Requirements on Patents - News, Articles, and Events

FTC, DOJ to Heighten Reporting Requirements on Patents

Michael W. Jahnke

January 7, 2013 | New York Law Journal

Click here to download a PDF of the full article.

The Federal Trade Commission and Department of Justice announced in August proposed revisions to the Hart-Scott-Rodino (HSR) Act's premerger notification rules to require enhanced reporting of transactions relating to patents of pharmaceutical, biological and diagnostic products. This article discusses the license reporting requirements, the valuation of those licenses and other issues that may emerge under the new rules, which are likely to take effect in the first quarter of 2013.

This article was first published in the January 7, 2013 issue of New York Law Journal. Permission for article reprint has been granted.

Michael Jahnke is a partner in the Washington, DC and New York offices of Loeb & Loeb LLP. He is co-chair of the firm's Antitrust Group.

This Web site may constitute "Attorney Advertising" under the New York Rules of Professional Conduct and under the law of other jurisdictions.
Your use of our Web site or its facilities constitutes your acceptance of the Terms of Use and Privacy Policy, which are accessible in the link at the bottom left of this page.